Alpha Teknova (TKNO) Other Non-Current Assets (2020 - 2026)
Alpha Teknova (TKNO) posted quarterly Other Non-Current Assets of $1.2 million for Q1 2026, down 9.4% year-over-year from $1.3 million in Q1 2025, and down 7.0% quarter-over-quarter from $1.3 million in Q4 2025.
Alpha Teknova (TKNO) Other Non-Current Assets (2020 - 2026) Analysis & Trends
Alpha Teknova (TKNO) has reported Other Non-Current Assets for 7 consecutive years, with $1.2 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Other Non-Current Assets fell 9.4% year-over-year to $1.2 million; the TTM figure through Mar 2026 stood at $1.2 million (down 9.4% YoY), while the FY2025 annual figure was $1.3 million, down 7.02% from the prior year.
- Other Non-Current Assets retreated to $1.2 million in Q1 2026 per TKNO's latest filing, from $1.3 million in the prior quarter.
- Across five years, Other Non-Current Assets topped out at $2.3 million in Q4 2022 and bottomed at $396000.0 in Q1 2022.
- Historically, Other Non-Current Assets has averaged $1.5 million across 5 years, with a median of $1.4 million in 2024.
- Annual changes were most pronounced in 2022 — Other Non-Current Assets soared 3955.17% — and 2024, when it fell 25.38%.
- Alpha Teknova's Other Non-Current Assets stood at $2.3 million in 2022, then fell by 17.76% to $1.9 million in 2023, then dropped by 25.38% to $1.4 million in 2024, then dropped by 7.02% to $1.3 million in 2025, then slipped by 7.0% to $1.2 million in 2026.
- Business Quant data shows TKNO's Other Non-Current Assets at $1.2 million in Q1 2026, $1.3 million in Q4 2025, and $1.3 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.43 Bn | 43.46 Bn | - | 56.35 Mn |
| 2 | Teva Pharmaceutical Industries | 43.68 Bn | 40.02 Bn | 2.15 Bn | 1.79 Bn |
| 3 | Zoetis | 32.49 Bn | 30.82 Bn | 1.05 Bn | 384.00 Mn |
| 4 | Takeda Pharmaceutical | 28.64 Bn | 22.84 Bn | 5.10 Bn | 503.80 Mn |
| 5 | United Therapeutics | 22.09 Bn | 19.42 Bn | 683.80 Mn | 239.50 Mn |
| 6 | Viatris | 19.03 Bn | 18.14 Bn | 1.46 Bn | 1.06 Bn |
| 7 | Neurocrine Biosciences | 15.47 Bn | 15.08 Bn | 935.80 Mn | 59.30 Mn |
| 8 | Elanco Animal Health | 12.03 Bn | 11.50 Bn | 798.00 Mn | 304.00 Mn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - | 13.00 Mn |
| 10 | Alpha Teknova | 395.29 Mn | 377.85 Mn | 4.89 Mn | 1.13 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.13 Mn |
| Mar 31, 2026 | 1.20 Mn |
| Dec 31, 2025 | 1.29 Mn |
| Sep 30, 2025 | 1.32 Mn |
| Jun 30, 2025 | 1.35 Mn |
| Mar 31, 2025 | 1.32 Mn |
| Dec 31, 2024 | 1.38 Mn |
| Sep 30, 2024 | 1.52 Mn |
| Jun 30, 2024 | 1.65 Mn |
| Mar 31, 2024 | 1.74 Mn |
| Dec 31, 2023 | 1.85 Mn |
| Sep 30, 2023 | 1.95 Mn |
| Jun 30, 2023 | 2.03 Mn |
| Mar 31, 2023 | 2.15 Mn |
| Dec 31, 2022 | 2.25 Mn |
| Sep 30, 2022 | 1.18 Mn |
| Jun 30, 2022 | 769,000.00 |
| Mar 31, 2022 | 396,000.00 |
| Dec 31, 2021 | 180,000.00 |
| Sep 30, 2021 | 29,000.00 |